NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $63,000 | -26.7% | 3,500 | -30.0% | 0.03% | -20.9% |
Q2 2021 | $86,000 | -14.0% | 5,000 | 0.0% | 0.04% | -20.4% |
Q1 2021 | $100,000 | +17.6% | 5,000 | 0.0% | 0.05% | +14.9% |
Q4 2020 | $85,000 | +2.4% | 5,000 | 0.0% | 0.05% | -7.8% |
Q3 2020 | $83,000 | -28.4% | 5,000 | 0.0% | 0.05% | -31.1% |
Q2 2020 | $116,000 | +30.3% | 5,000 | 0.0% | 0.07% | +12.1% |
Q1 2020 | $89,000 | – | 5,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |